CUSIP: N5749R100
Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / Common Shares, (euro)0.09 nominal value per share
-
Shares outstanding
-
75,893,250
-
Total 13F shares
-
5,703,167
-
Share change
-
-128,361
-
Total reported value
-
$110,530,000
-
Price per share
-
$19.40
-
Number of holders
-
16
-
Value change
-
-$2,557,404
-
Number of buys
-
6
-
Number of sells
-
8
Security key
N5749R100
Report period
Q4 2017
Institutions
16
Top holders
10
Reporting periods
Holder history for CUSIP N5749R100
Recent filing periods:
Top shareholders of MRUS - Merus N.V. - Common Shares, (euro)0.09 nominal value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
Institutional Holders of Merus N.V. - Common Shares, (euro)0.09 nominal value per share (MRUS) as of Q4 2017
As of 31 Dec 2017,
Merus N.V. - Common Shares, (euro)0.09 nominal value per share (MRUS) was held by
16 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,703,167 shares.
The largest 10 holders included
Novo Holdings A/S, WELLINGTON MANAGEMENT GROUP LLP, BAKER BROS. ADVISORS LP, FRANKLIN RESOURCES INC, Tekla Capital Management LLC, PRICE T ROWE ASSOCIATES INC /MD/, Rock Springs Capital Management LP, PLATINUM INVESTMENT MANAGEMENT LTD, Iguana Healthcare Management, LLC, and DEUTSCHE BANK AG\.
This page lists
16
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
Compare Q4 2017 vs Q3 2017 Across Filers
| Investor |
Q3 2017 Shares |
Q4 2017 Shares |
Share Diff |
Share Chg % |
Q3 2017 Value $ |
Q4 2017 Value $ |
Value Diff $ |
Value Chg % |
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.